Is Omnicell Stock a Good Investment?

Omnicell Investment Advice

OMCL

To provide specific investment advice or recommendations on Omnicell stock, we recommend investors consider the following general factors when evaluating Omnicell. This will help you to make an informed decision on whether to include Omnicell in one of your diversified portfolios:

Examine Omnicell's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Omnicell's leadership team and their track record. Good management can help Omnicell navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Technology space and any emerging trends that could impact Omnicell's business and its evolving consumer preferences.
Compare Omnicell's performance and market position to its competitors. Analyze how Omnicell is positioned in terms of product offerings, innovation, and market share.
Check if Omnicell pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Omnicell's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Omnicell stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Omnicell is a good investment.

Sell

Buy

Strong Hold

Our recommendation module complements current analysts and expert consensus on Omnicell. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Omnicell is not overpriced, please check all Omnicell fundamentals, including its price to book, total debt, target price, as well as the relationship between the ebitda and cash flow from operations . Given that Omnicell has a price to earning of 64.95 X, we recommend you to check out Omnicell market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very Low	Details
Economic Sensitivity	Actively responds to the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Strong	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Omnicell Stock

Researching Omnicell's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity had not issued any dividends in recent years.

To determine if Omnicell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Omnicell's research are outlined below:

	Omnicell generated a negative expected return over the last 90 days
	Omnicell has high historical volatility and very poor performance
	Omnicell has a strong financial position based on the latest SEC filings
	Over 98.0% of the company shares are owned by institutional investors
	Latest headline from news.google.com: What analysts say about Omnicell Inc. stock - Tremendous return on equity - Jammu Links News

Omnicell Quarterly Liabilities And Stockholders Equity

2.15 Billion

Omnicell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Omnicell. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Omnicell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	8th of February 2024 Upcoming Quarterly Report	View
	7th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	8th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Omnicell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Omnicell's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2011-05-02	2011-03-31	0.1	0.11	0.01	10
2010-10-27	2010-09-30	0.1	0.11	0.01	10
2010-04-26	2010-03-31	0.1	0.09	-0.01	10
2010-01-28	2009-12-31	0.1	0.11	0.01	10
2006-01-30	2005-12-31	0.07	0.08	0.01	14
2005-10-20	2005-09-30	0.04	0.05	0.01	25
2004-04-14	2004-03-31	0.07	0.08	0.01	14
2013-05-02	2013-03-31	0.19	0.21	0.02	10

Know Omnicell's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Omnicell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omnicell backward and forwards among themselves. Omnicell's institutional investor refers to the entity that pools money to purchase Omnicell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Morgan Stanley - Brokerage Accounts	2025-03-31	790.8 K
Federated Hermes Inc	2025-03-31	746.5 K
Arrowmark Colorado Holdings, Llc (arrowmark Partners)	2025-03-31	714.7 K
Royal Bank Of Canada	2025-03-31	685.2 K
Charles Schwab Investment Management Inc	2025-03-31	613.8 K
Mirae Asset Global Etfs Holdings Ltd.	2025-03-31	592.1 K
Northern Trust Corp	2025-03-31	509.4 K
Wellington Management Company Llp	2025-03-31	496.7 K
Qube Research & Technologies	2025-03-31	472.6 K
Blackrock Inc	2025-03-31	8 M
Vanguard Group Inc	2025-03-31	5.6 M

Note, although Omnicell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omnicell's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B.

Market Cap

1.64 Billion

Omnicell's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.01	0.02
Return On Assets	0.01	0.01
Return On Equity	0.01	0.01

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.

Determining Omnicell's profitability involves analyzing its financial statements and using various financial metrics to determine if Omnicell is a good buy. For example, gross profit margin measures Omnicell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Omnicell's profitability and make more informed investment decisions.

Omnicell's Earnings Breakdown by Geography

Evaluate Omnicell's management efficiency

At this time, Omnicell's Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.01 this year, although the value of Return On Capital Employed will most likely fall to 0.0002. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Intangibles To Total Assets will most likely fall to 0.23. Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.

	Last Reported	Projected for Next Year
Book Value Per Share	27.00	28.35
Tangible Book Value Per Share	5.69	5.97
Enterprise Value Over EBITDA	22.90	22.05
Price Book Value Ratio	1.65	1.57
Enterprise Value Multiple	22.90	22.05
Price Fair Value	1.65	1.57
Enterprise Value	1.9 B	1.7 B

Omnicell showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.

Beta

0.779

Basic technical analysis of Omnicell Stock

As of the 19th of July, Omnicell holds the Risk Adjusted Performance of (0.05), variance of 9.08, and Coefficient Of Variation of (1,518). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell information ratio and potential upside to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 26.88 per share. Given that Omnicell has information ratio of (0.11), we recommend you to check out Omnicell's recent market performance to make sure the company can sustain itself at a future point.

Omnicell's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omnicell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omnicell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omnicell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Ghoshal Kaushik few days ago Acquisition by Ghoshal Kaushik of 5717 shares of Omnicell subject to Rule 16b-3
		Corey Manley over a month ago Disposition of 332 shares by Corey Manley of Omnicell at 29.25 subject to Rule 16b-3
		Seim Robin Gene over a month ago Acquisition by Seim Robin Gene of 6828 shares of Omnicell subject to Rule 16b-3
		Nchacha Etta over three months ago Acquisition by Nchacha Etta of 66633 shares of Omnicell subject to Rule 16b-3
		Corey Manley over three months ago Disposition of 2545 shares by Corey Manley of Omnicell at 38.06 subject to Rule 16b-3
		Corey Manley over three months ago Disposition of tradable shares by Corey Manley of Omnicell at 33.0 subject to Rule 16b-3
		Randall Lipps over three months ago Acquisition by Randall Lipps of 10561 shares of Omnicell at 33.1289 subject to Rule 16b-3
		Joseph Spears over three months ago Disposition of 138 shares by Joseph Spears of Omnicell at 28.3 subject to Rule 16b-3
		Nchacha Etta over three months ago Disposition of 717 shares by Nchacha Etta of Omnicell at .61 subject to Rule 16b-3
		Bauer Joanne B over six months ago Disposition of 3318 shares by Bauer Joanne B of Omnicell at 55.0377 subject to Rule 16b-3
		Randall Lipps over six months ago Disposition of 4202 shares by Randall Lipps of Omnicell at 46.01 subject to Rule 16b-3
		Parrish Mark W over six months ago Disposition of 12000 shares by Parrish Mark W of Omnicell at 47.3032 subject to Rule 16b-3

Omnicell's Outstanding Corporate Bonds

Omnicell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omnicell uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omnicell bonds can be classified according to their maturity, which is the date when Omnicell has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	MPLX LP 4125 Corp Bond US55336VAK61	View
	BNP Paribas FRN Corp Bond USF1R15XK367	View
	ON SEMICONDUCTOR P Corp Bond US682189AQ81	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View
	Valero Energy Partners Corp Bond US91914JAA07	View
	OMNICOM GROUP INC Corp Bond US68217FAA03	View

View All Omnicell Corporate Bonds

Understand Omnicell's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Omnicell's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.05)
	Market Risk Adjusted Performance	(0.12)
	Mean Deviation	2.02
	Coefficient Of Variation	(1,518)
	Standard Deviation	3.01
	Variance	9.08
	Information Ratio	(0.11)
	Jensen Alpha	(0.42)
	Total Risk Alpha	(0.63)
	Treynor Ratio	(0.13)
	Maximum Drawdown	18.41
	Value At Risk	(3.90)
	Potential Upside	3.34
	Skewness	(1.94)
	Kurtosis	10.34

	Risk Adjusted Performance	(0.05)
	Market Risk Adjusted Performance	(0.12)
	Mean Deviation	2.02
	Coefficient Of Variation	(1,518)
	Standard Deviation	3.01
	Variance	9.08
	Information Ratio	(0.11)
	Jensen Alpha	(0.42)
	Total Risk Alpha	(0.63)
	Treynor Ratio	(0.13)
	Maximum Drawdown	18.41
	Value At Risk	(3.90)
	Potential Upside	3.34
	Skewness	(1.94)
	Kurtosis	10.34

Consider Omnicell's intraday indicators

Omnicell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Omnicell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	38430.58
	Daily Balance Of Power	(0.62)
	Rate Of Daily Change	0.96
	Day Median Price	27.74
	Day Typical Price	27.45
	Price Action Indicator	(1.40)
	Period Momentum Indicator	(1.09)
	Relative Strength Index	53.44

Omnicell Corporate Filings

	18th of June 2025 Other Reports	View Verify
F4	17th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
8K	5th of June 2025 Report filed with the SEC to announce major events that shareholders should know about	View Verify
10Q	7th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify

Omnicell time-series forecasting models is one of many Omnicell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omnicell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Omnicell Stock media impact

There is far too much social signal, news, headlines, and media speculation about Omnicell that are available to investors today. This information is accessible both publicly - through Omnicell's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Omnicell-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.

A primary focus of Omnicell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Omnicell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Omnicell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Omnicell alpha.

Omnicell Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Omnicell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Omnicell Historical Investor Sentiment

Investor biases related to Omnicell's public news can be used to forecast risks associated with an investment in Omnicell. The trend in average sentiment can be used to explain how an investor holding Omnicell can time the market purely based on public headlines and social activities around Omnicell. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Omnicell's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Omnicell and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Omnicell news discussions. The higher the estimate score, the more favorable the investor's outlook on Omnicell.

Omnicell Corporate Management

Joseph Spears	Principal Chief Accounting Officer	Profile
Kathleen Nemeth	Senior Relations	Profile
Vicki MacDevitt	Chief Staff	Profile
Sara Dalmasso	Senior International	Profile
Minoo Mortazavi	Senior Operations	Profile

When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports: